BR9305213A - Sal de cefalosporina, processos para a sua preparação, aplicação do dito sal e preparação farmacêutica - Google Patents
Sal de cefalosporina, processos para a sua preparação, aplicação do dito sal e preparação farmacêuticaInfo
- Publication number
- BR9305213A BR9305213A BR9305213A BR9305213A BR9305213A BR 9305213 A BR9305213 A BR 9305213A BR 9305213 A BR9305213 A BR 9305213A BR 9305213 A BR9305213 A BR 9305213A BR 9305213 A BR9305213 A BR 9305213A
- Authority
- BR
- Brazil
- Prior art keywords
- salt
- preparation
- processes
- application
- cephalosporin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D333/40—Thiophene-2-carboxylic acid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4244069A DE4244069A1 (de) | 1992-12-24 | 1992-12-24 | Cephalosporinsalze und Verfahren zu deren Herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9305213A true BR9305213A (pt) | 1994-07-26 |
Family
ID=6476531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9305213A BR9305213A (pt) | 1992-12-24 | 1993-12-23 | Sal de cefalosporina, processos para a sua preparação, aplicação do dito sal e preparação farmacêutica |
Country Status (27)
| Country | Link |
|---|---|
| EP (1) | EP0603755A3 (pt) |
| JP (1) | JPH06247974A (pt) |
| KR (1) | KR940014406A (pt) |
| CN (1) | CN1093089A (pt) |
| AU (1) | AU672056B2 (pt) |
| BR (1) | BR9305213A (pt) |
| CA (1) | CA2112196A1 (pt) |
| CZ (1) | CZ285693A3 (pt) |
| DE (1) | DE4244069A1 (pt) |
| EC (1) | ECSP930947A (pt) |
| FI (1) | FI935797A (pt) |
| HR (1) | HRP931517A2 (pt) |
| HU (1) | HUT66141A (pt) |
| IL (1) | IL108134A0 (pt) |
| MA (1) | MA23070A1 (pt) |
| MX (1) | MX9308061A (pt) |
| NO (1) | NO934791L (pt) |
| NZ (1) | NZ250547A (pt) |
| OA (1) | OA09846A (pt) |
| PL (1) | PL301623A1 (pt) |
| SI (1) | SI9300685A (pt) |
| SK (1) | SK146293A3 (pt) |
| TN (1) | TNSN93138A1 (pt) |
| TW (1) | TW353662B (pt) |
| UY (1) | UY23683A1 (pt) |
| YU (1) | YU80593A (pt) |
| ZA (1) | ZA939609B (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1401825E (pt) | 2001-06-11 | 2009-10-23 | Virochem Pharma Inc | Compostos e métodos para o tratamento ou para a prevenção de infecções com flavivírus |
| US8329924B2 (en) | 2001-06-11 | 2012-12-11 | Vertex Pharmaceuticals (Canada) Incorporated | Compounds and methods for the treatment or prevention of Flavivirus infections |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1643325B2 (de) * | 1967-07-07 | 1976-05-06 | Hoechst Ag, 6000 Frankfurt | 3-aminoacylaminothiophene und verfahren zu ihrer herstellung |
-
1992
- 1992-12-24 DE DE4244069A patent/DE4244069A1/de not_active Withdrawn
-
1993
- 1993-06-28 EC EC1993000947A patent/ECSP930947A/es unknown
- 1993-09-17 TW TW082107623A patent/TW353662B/zh active
- 1993-12-09 UY UY23683A patent/UY23683A1/es unknown
- 1993-12-16 MX MX9308061A patent/MX9308061A/es unknown
- 1993-12-17 EP EP9393120375A patent/EP0603755A3/en not_active Withdrawn
- 1993-12-21 CZ CZ932856A patent/CZ285693A3/cs unknown
- 1993-12-22 NZ NZ250547A patent/NZ250547A/en unknown
- 1993-12-22 AU AU52667/93A patent/AU672056B2/en not_active Ceased
- 1993-12-22 FI FI935797A patent/FI935797A/fi not_active Application Discontinuation
- 1993-12-22 YU YU80593A patent/YU80593A/sh unknown
- 1993-12-22 IL IL10813493A patent/IL108134A0/xx unknown
- 1993-12-22 JP JP5323921A patent/JPH06247974A/ja active Pending
- 1993-12-22 ZA ZA939609A patent/ZA939609B/xx unknown
- 1993-12-22 CA CA002112196A patent/CA2112196A1/en not_active Abandoned
- 1993-12-22 SK SK1462-93A patent/SK146293A3/sk unknown
- 1993-12-23 CN CN93112787A patent/CN1093089A/zh active Pending
- 1993-12-23 PL PL93301623A patent/PL301623A1/xx unknown
- 1993-12-23 HR HR931517A patent/HRP931517A2/hr not_active Application Discontinuation
- 1993-12-23 BR BR9305213A patent/BR9305213A/pt not_active Application Discontinuation
- 1993-12-23 HU HU9303747A patent/HUT66141A/hu unknown
- 1993-12-23 NO NO934791A patent/NO934791L/no unknown
- 1993-12-23 TN TNTNSN93138A patent/TNSN93138A1/fr unknown
- 1993-12-24 MA MA23380A patent/MA23070A1/fr unknown
- 1993-12-24 SI SI9300685A patent/SI9300685A/sl unknown
- 1993-12-24 KR KR1019930029471A patent/KR940014406A/ko not_active Application Discontinuation
- 1993-12-24 OA OA60452A patent/OA09846A/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI9300685A (en) | 1994-06-30 |
| FI935797A (fi) | 1994-06-25 |
| CA2112196A1 (en) | 1994-06-25 |
| ECSP930947A (es) | 1994-11-16 |
| UY23683A1 (es) | 1993-12-17 |
| CZ285693A3 (en) | 1994-07-13 |
| OA09846A (fr) | 1994-08-15 |
| MX9308061A (es) | 1994-06-30 |
| AU672056B2 (en) | 1996-09-19 |
| FI935797A0 (fi) | 1993-12-22 |
| EP0603755A3 (en) | 1994-09-28 |
| IL108134A0 (en) | 1994-04-12 |
| YU80593A (sh) | 1996-10-09 |
| PL301623A1 (en) | 1994-06-27 |
| SK146293A3 (en) | 1994-12-07 |
| CN1093089A (zh) | 1994-10-05 |
| NO934791D0 (no) | 1993-12-23 |
| HU9303747D0 (en) | 1994-04-28 |
| HRP931517A2 (en) | 1994-12-31 |
| NO934791L (no) | 1994-06-27 |
| MA23070A1 (fr) | 1994-07-01 |
| NZ250547A (en) | 1995-08-28 |
| KR940014406A (ko) | 1994-07-18 |
| TNSN93138A1 (fr) | 1994-03-17 |
| EP0603755A2 (de) | 1994-06-29 |
| ZA939609B (en) | 1994-08-11 |
| JPH06247974A (ja) | 1994-09-06 |
| DE4244069A1 (de) | 1994-06-30 |
| TW353662B (en) | 1999-03-01 |
| HUT66141A (en) | 1994-09-28 |
| AU5266793A (en) | 1994-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3292493A (en) | Aqueous pharmaceutical suspension for pharmaceutical actives | |
| BR9601028A (pt) | Compostos processo para sua preparação processo para a produção de preparações farmacêuticas preparação farmacêutica medicamento e uso | |
| NO954146D0 (no) | Belagte farmasöytiske preparater | |
| KR950703566A (ko) | 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof] | |
| EE04614B1 (et) | Inhaleeritav farmatseutiline preparaat, selles sisalduvate iprotroopiumisoolade kasutamine ja iprotroopiumisool | |
| ES551483A0 (es) | Procedimiento para la purificacion de una proteina | |
| PT918059E (pt) | Derivados substituidos de imidazolidina a sua sintese a sua utilizacao e preparacoes farmaceuticas contendo os mesmos | |
| BR9609327A (pt) | Novos derivados de oxazolidinona processos para sua preparação e agentes farmacêuticos que contêm estes compostos | |
| BR9301922A (pt) | Transdutor para medicao de forca | |
| BR9202325A (pt) | Composto,processo para a sua preparacao,preparado farmaceutico e processo para a sua preparacao | |
| PT87989A (pt) | Processo para a preparacao de derivados olefinicos de carbonitrilo e sua utilizacao | |
| BR9607095A (pt) | Composto composição farmacêutica e processos para fabricar e para administrar um composto | |
| PT100671A (pt) | Sal de l-ascorbato de 16-descarboxi-16-hidroxi-metilanfotericina b e processo para a sua preparacao | |
| BR9303456A (pt) | Compostos,processo para sua preparacao,medicamentos,processo para sua preparacao e emprego | |
| ES535625A0 (es) | Un procedimiento para la preparacion de 9-deoxo-9a-metil-9a-aza-9a-homoeritromicina d o una sal de la misma | |
| BR9200586A (pt) | Composto de hidrazona ou seu sal,processos para a sua producao,composto intermediario para producao dos ditos compostos de hidrazona,e composicao e metodo pesticida | |
| NO934145D0 (no) | Farmas!ytiske forbindelser | |
| FI931251A0 (fi) | Farmaceutiska foereningar | |
| BR9301923A (pt) | Transdutor para medicao de forca | |
| BR9612057A (pt) | Comprimido de liberação rápida contendo ácido tolfenâmico ou um sal farmaceuticamente aceitável do mesmo | |
| ITMI913318A0 (it) | Preparazioni farmaceutiche a liberazione programmata | |
| BR9305213A (pt) | Sal de cefalosporina, processos para a sua preparação, aplicação do dito sal e preparação farmacêutica | |
| BR9603164A (pt) | Compostos processo para a preparação dos mesmos processo para a produção de preparações farmacêuticas preparação farmacêutica medicamentos e uso de compostos | |
| BR9302734A (pt) | Processo para a prepparacao e purificacao de uma solucao de sal de hidroxilamonio | |
| BR9300390A (pt) | Composto de formula (i) ou um sal do mesmo farmaceuticamente aceitavel e processo para sua preparacao |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EG | Technical examination (opinion): publication of technical examination (opinion) | ||
| FC | Decision: refusal |